IPI Legacy Liquidation Co., Formerly Known as Impel Pharmaceuticals, Announces Confirmation and Effective Date of Joint Plan of Liquidation

Posted on by

Impel’s Common Stock to Be Cancelled, With No Action Required by Shareholders SEATTLE, April 5, 2024 /PRNewswire/ — IPI Legacy Liquidation Co., formerly known as Impel Pharmaceuticals Inc., (“Impel”) and its affiliate, Impel NeuroPharma Australia PTY LTD, (together with Impel, the…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.